Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Dividend Declaration

6 Feb 2024 11:07

RNS Number : 1954C
Maven Income and Growth VCT 3 PLC
06 February 2024
 

 

Maven Income and Growth VCT 3 PLC

 

Proposed Final Dividend

 

On 18 December 2023, the Directors of Maven Income and Growth VCT 3 PLC ("the Company") announced that the unaudited net asset value of the Company as at 30 November 2023 was 52.48p per Ordinary Share.

 

The Directors propose that a final dividend of 2.15p per Ordinary Share, in respect of the year ended 30 November 2023, be paid on 3 May 2024 to Shareholders on the register at close of business on 22 March 2024.

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration a number of factors, including the availability of surplus revenue, the realisation of capital gains, the adequacy of distributable reserves and the VCT qualifying level. The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the conditions set out above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end. This final dividend will bring total distributions for the financial year to 2.65p per Ordinary Share, representing an annual yield of 4.62%.

 

Since the Company's launch, and after receipt of this final dividend, a total of 99.72p per share will have been distributed in tax-free dividends. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

 

Dividend Investment Scheme

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances. Terms & conditions of the scheme, together with a mandate form, are available from the Company's webpage at: mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 3 May 2024, should ensure that a mandate form is received by the Company's Registrar, The City Partnership (UK) Limited, prior to the dividend election date of 12 April 2024. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2023 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

6 February 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAFAKEELLEFA
Date   Source Headline
1st Mar 20164:14 pmRNSDirector/PDMR Shareholding
17th Feb 20165:02 pmRNSTransaction in Own Shares
10th Feb 20163:39 pmRNSForm 8.3 - Tangent Communications PLC
9th Feb 20164:41 pmRNSTransaction in Own Shares
8th Feb 201612:30 pmRNSTransaction in Own Shares
4th Feb 201610:48 amRNSTransaction in Own Shares
28th Jan 20162:47 pmRNSNet Asset Value & Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
30th Nov 201512:36 pmRNSTransaction in Own Shares
23rd Oct 201512:04 pmRNSNet Asset Value(s)
4th Sep 201510:51 amRNSPortfolio Update
24th Aug 20153:37 pmRNSStatement re Dividend Investment Scheme
10th Jul 20155:07 pmRNSHalf Yearly Report
15th Jun 20155:09 pmRNSDirector/PDMR Shareholding
12th Jun 201510:00 amRNSIssue of Equity
5th Jun 20153:17 pmRNSNet Asset Value(s)
27th May 20155:18 pmRNSTransaction in Own Shares
30th Apr 201512:43 pmRNSTransaction in Own Shares
29th Apr 20153:44 pmRNSTransaction in Own Shares
22nd Apr 20153:11 pmRNSTransaction in Own Shares
21st Apr 20153:45 pmRNSTransaction in Own Shares
16th Apr 20154:17 pmRNSNet Asset Value(s)
15th Apr 20153:16 pmRNSDirectorate Change
15th Apr 20153:13 pmRNSDirectorate Change
15th Apr 20153:12 pmRNSResult of AGM
13th Apr 20153:11 pmRNSIssue of Equity
4th Mar 20155:16 pmRNSAnnual Financial Report
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201511:24 amRNSDirector/PDMR Shareholding
20th Feb 20152:47 pmRNSIssue of Equity
11th Feb 201511:40 amRNSNet Asset Value(s)
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
20th Jan 20159:48 amRNSStatement re Offers for Subscription
9th Jan 201510:17 amRNSDirector Declaration
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
6th Nov 20145:23 pmRNSTransaction in Own Shares
5th Nov 20142:30 pmRNSTransaction in Own Shares
4th Nov 20144:46 pmRNSTransaction in Own Shares
4th Nov 20144:41 pmRNSDirector/PDMR Shareholding
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20142:46 pmRNSInterim Management Statement
3rd Oct 20144:23 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
26th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 20144:41 pmRNSTransaction in Own Shares
12th Aug 20143:36 pmRNSTransaction in Own Shares
11th Aug 20144:22 pmRNSTransaction in Own Shares
4th Aug 20145:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.